about
Data Analysis Strategies for Protein Microarrays.Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.Self-assembled protein arrays from an Ornithodoros moubata salivary gland expression library.CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease featuresBiomarker discovery by novel sensors based on nanoproteomics approaches.Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow.Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?Nanotechniques in proteomics: protein microarrays and novel detection platforms.Introduction to the diagnosis and classification of monocytic-lineage leukemias by flow cytometry.Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression.Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis.The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia.Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene.Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.Cell-cycle distribution of different cell compartments in normal versus reactive bone marrow: a frame of reference for the study of dysplastic hematopoiesis.Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes.Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterationsEvaluation of homo- and hetero-functionally activated glass surfaces for optimized antibody arraysSubjects with chronic lymphocytic leukaemia-like B-cell clones with stereotyped B-cell receptors frequently show MDS-associated phenotypes on myeloid cellsStandardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working GroupQuantitative analysis of the expression of glycosylphosphatidylinositol-anchored proteins during the maturation of different hematopoietic cell compartments of normal bone marrowExpression of CD44 and CD35 during normal and myelodysplastic erythropoiesis
P50
Q31127442-2B068D0E-6998-4419-93DC-E4622925BB89Q33399314-80484D63-AEB4-4BEB-A5DE-509E2D3893E6Q34472500-7EC60F6C-954B-41FE-AA91-B81C61C03476Q34543082-74ED5372-4BEA-49E8-B7B7-A1A45BC3B025Q35831485-8115CF4B-8E71-44D9-A42E-FC44732DE743Q36034814-7D7B9B72-0930-4569-A474-EBCD0E60AABDQ36366988-DE1E2B7B-CBEE-4530-AF40-8895FE533E14Q37908677-3C5DE725-ACD9-4F46-8B70-24EE512361DBQ38568509-BDB39329-9201-4004-96B0-D63E5F74C0B5Q39272518-FB39B9A8-0B57-4E3E-8104-5034456EE799Q41604021-CEF022E4-C08B-4C75-B2CF-92D223DCD59CQ44959863-9125DBA6-0573-4AD2-9AF0-7B89216E7871Q46704588-464BEE39-4263-4661-8B39-9ED4D38D638BQ47393763-E87CA9CA-E779-4264-8D3D-74480A40431EQ48633334-6F43B95A-EEF9-4D4D-9A53-971F70BEE401Q50472681-7823D7CA-2E77-46E3-879D-18E7CB80F413Q50492462-0D0DDC29-7264-4F8F-BA39-EB7B814E6E2CQ50533869-A5F657F8-1F85-44EC-8B2D-F26B3A210668Q51826205-22F99335-D676-47A6-964B-D97211904A0AQ53088619-1DEDCBD1-FBBA-4380-B47D-E29165DDED3CQ58010072-1BBBF796-999E-4CC8-B2F3-BC7E518E12C0Q58494037-55DF3E07-C939-4BD9-8A44-94842716E500Q60724701-46928F4D-2FD9-475E-9E57-D48F27FADE65Q63346979-8B8F3416-DBD2-475E-9B1D-70BB2301A0E9Q79273872-28D98822-8B78-4BC7-9E36-BEF7B825956DQ86516791-C61A5E7A-1513-4AF6-8B8A-BEFED6BF9BAE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sergio Matarraz
@ast
Sergio Matarraz
@en
Sergio Matarraz
@es
Sergio Matarraz
@nl
type
label
Sergio Matarraz
@ast
Sergio Matarraz
@en
Sergio Matarraz
@es
Sergio Matarraz
@nl
prefLabel
Sergio Matarraz
@ast
Sergio Matarraz
@en
Sergio Matarraz
@es
Sergio Matarraz
@nl
P106
P21
P31
P496
0000-0003-4634-8005